Annual FCF
-$23.45 M
-$28.59 M-556.06%
31 December 2023
Summary:
Co-Diagnostics annual free cash flow is currently -$23.45 million, with the most recent change of -$28.59 million (-556.06%) on 31 December 2023. During the last 3 years, it has fallen by -$50.84 million (-185.60%). CODX annual FCF is now -158.02% below its all-time high of $40.41 million, reached on 31 December 2021.CODX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$7.40 M
-$2.10 M-39.62%
30 September 2024
Summary:
Co-Diagnostics quarterly free cash flow is currently -$7.40 million, with the most recent change of -$2.10 million (-39.62%) on 30 September 2024. Over the past year, it has dropped by -$1.40 million (-23.37%). CODX quarterly FCF is now -137.99% below its all-time high of $19.49 million, reached on 31 December 2020.CODX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$26.84 M
-$1.40 M-5.51%
30 September 2024
Summary:
Co-Diagnostics TTM free cash flow is currently -$26.84 million, with the most recent change of -$1.40 million (-5.51%) on 30 September 2024. Over the past year, it has dropped by -$4.34 million (-19.26%). CODX TTM FCF is now -148.68% below its all-time high of $55.14 million, reached on 30 September 2021.CODX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CODX Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -556.1% | -23.4% | -19.3% |
| 3 y3 years | -185.6% | -165.3% | -148.7% |
| 5 y5 years | -468.9% | -497.4% | -438.0% |
CODX Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -158.0% | at low | -165.3% | +16.7% | -148.7% | at low |
| 5 y | 5 years | -158.0% | at low | -138.0% | +16.7% | -148.7% | at low |
| alltime | all time | -158.0% | at low | -138.0% | +16.7% | -148.7% | at low |
Co-Diagnostics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$7.40 M(+39.6%) | -$26.84 M(+5.5%) |
| June 2024 | - | -$5.30 M(-40.4%) | -$25.44 M(-3.1%) |
| Mar 2024 | - | -$8.89 M(+69.6%) | -$26.24 M(+11.9%) |
| Dec 2023 | -$23.45 M(-556.1%) | -$5.24 M(-12.6%) | -$23.45 M(+4.2%) |
| Sept 2023 | - | -$6.00 M(-1.7%) | -$22.51 M(+44.1%) |
| June 2023 | - | -$6.10 M(+0.1%) | -$15.62 M(+86.7%) |
| Mar 2023 | - | -$6.10 M(+41.7%) | -$8.37 M(-262.7%) |
| Dec 2022 | $5.14 M(-87.3%) | -$4.30 M(-584.4%) | $5.14 M(-63.8%) |
| Sept 2022 | - | $888.30 K(-22.5%) | $14.20 M(-42.4%) |
| June 2022 | - | $1.15 M(-84.5%) | $24.66 M(-30.9%) |
| Mar 2022 | - | $7.41 M(+55.8%) | $35.69 M(-11.7%) |
| Dec 2021 | $40.41 M(+47.5%) | $4.76 M(-58.1%) | $40.41 M(-26.7%) |
| Sept 2021 | - | $11.34 M(-6.9%) | $55.14 M(+5.5%) |
| June 2021 | - | $12.18 M(+0.4%) | $52.26 M(+27.6%) |
| Mar 2021 | - | $12.13 M(-37.8%) | $40.96 M(+49.5%) |
| Dec 2020 | $27.39 M | $19.49 M(+130.5%) | $27.39 M(+338.0%) |
| Sept 2020 | - | $8.46 M(+858.6%) | $6.25 M(-281.7%) |
| June 2020 | - | $882.10 K(-161.4%) | -$3.44 M(-39.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$1.44 M(-12.9%) | -$5.71 M(+1.2%) |
| Dec 2019 | -$5.64 M(+36.8%) | -$1.65 M(+33.0%) | -$5.64 M(+13.0%) |
| Sept 2019 | - | -$1.24 M(-10.3%) | -$4.99 M(+1.3%) |
| June 2019 | - | -$1.38 M(+0.9%) | -$4.93 M(+9.2%) |
| Mar 2019 | - | -$1.37 M(+37.0%) | -$4.51 M(+9.5%) |
| Dec 2018 | -$4.12 M(+23.4%) | -$999.50 K(-15.0%) | -$4.12 M(-0.8%) |
| Sept 2018 | - | -$1.18 M(+21.5%) | -$4.15 M(-8.4%) |
| June 2018 | - | -$968.00 K(-1.0%) | -$4.53 M(+17.5%) |
| Mar 2018 | - | -$978.20 K(-5.1%) | -$3.86 M(+15.5%) |
| Dec 2017 | -$3.34 M(+152.2%) | -$1.03 M(-33.7%) | -$3.34 M(+16.4%) |
| Sept 2017 | - | -$1.55 M(+428.1%) | -$2.87 M(+77.9%) |
| June 2017 | - | -$294.40 K(-36.1%) | -$1.61 M(+5.3%) |
| Mar 2017 | - | -$460.80 K(-17.8%) | -$1.53 M(+15.7%) |
| Dec 2016 | -$1.32 M(-19.7%) | -$560.60 K(+88.1%) | -$1.32 M(+73.4%) |
| Sept 2016 | - | -$298.10 K(+39.6%) | -$763.90 K(+64.0%) |
| June 2016 | - | -$213.60 K(-15.3%) | -$465.80 K(+84.7%) |
| Mar 2016 | - | -$252.20 K | -$252.20 K |
| Dec 2015 | -$1.65 M | - | - |
FAQ
- What is Co-Diagnostics annual free cash flow?
- What is the all time high annual FCF for Co-Diagnostics?
- What is Co-Diagnostics annual FCF year-on-year change?
- What is Co-Diagnostics quarterly free cash flow?
- What is the all time high quarterly FCF for Co-Diagnostics?
- What is Co-Diagnostics quarterly FCF year-on-year change?
- What is Co-Diagnostics TTM free cash flow?
- What is the all time high TTM FCF for Co-Diagnostics?
- What is Co-Diagnostics TTM FCF year-on-year change?
What is Co-Diagnostics annual free cash flow?
The current annual FCF of CODX is -$23.45 M
What is the all time high annual FCF for Co-Diagnostics?
Co-Diagnostics all-time high annual free cash flow is $40.41 M
What is Co-Diagnostics annual FCF year-on-year change?
Over the past year, CODX annual free cash flow has changed by -$28.59 M (-556.06%)
What is Co-Diagnostics quarterly free cash flow?
The current quarterly FCF of CODX is -$7.40 M
What is the all time high quarterly FCF for Co-Diagnostics?
Co-Diagnostics all-time high quarterly free cash flow is $19.49 M
What is Co-Diagnostics quarterly FCF year-on-year change?
Over the past year, CODX quarterly free cash flow has changed by -$1.40 M (-23.37%)
What is Co-Diagnostics TTM free cash flow?
The current TTM FCF of CODX is -$26.84 M
What is the all time high TTM FCF for Co-Diagnostics?
Co-Diagnostics all-time high TTM free cash flow is $55.14 M
What is Co-Diagnostics TTM FCF year-on-year change?
Over the past year, CODX TTM free cash flow has changed by -$4.34 M (-19.26%)